---
trial_id: 1054
discovery_date: 2022-07-01 09:01:12.701636
date: 2022-07-01 09:01:12.701636
title: "A Post Marketing Surveillance on LutatheraÂ® (Lutetium (177Lu) Oxodotreotide, 177Lu-DOTA0-Tyr3-Octreotate) in Patients With Somatostatin Receptor Positive Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) in Korea"
summary: |
  
link: 'https://www.novartis.com//clinicaltrials/study/nct04946305'
published_date: NaT
trial_source: Novartis
relevant: 
options:
  unlisted: false
---
